Truist Financial
FLGT icon

Truist Financial’s Fulgent Genetics FLGT Stock Holding History

Truist Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,991
Closed -$318K – 2648
2023
Q4 		$318K Sell
10,991
-355
-3% -$9.5K ﹤0.01% 2276
2023
Q3 		$303K Buy
11,346
+1,124
+11% +$38.4K ﹤0.01% 2235
2023
Q2 		$379K Sell
10,222
-3,014
-23% -$105K ﹤0.01% 2125
2023
Q1 		$413K Hold
13,236
– – ﹤0.01% 2090
2022
Q4 		$394K Buy
+13,236
New +$474K ﹤0.01% 2112
2022
Q3 		– Sell
-7,170
Closed -$391K – 2572
2022
Q2 		$391K Sell
7,170
-15,484
-68% -$851K ﹤0.01% 2056
2022
Q1 		$1.41M Buy
22,654
+2,490
+12% +$164K ﹤0.01% 1456
2021
Q4 		$2.03M Sell
20,164
-15
-0.1% -$1.32K ﹤0.01% 1286
2021
Q3 		$1.81M Buy
20,179
+15,756
+356% +$1.43M ﹤0.01% 1324
2021
Q2 		$408K Buy
+4,423
New +$353K ﹤0.01% 2194

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Truist Financial's FLGT Position: Q1 2024 in Review

Truist Financial sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 10,991 shares — an estimated $318K sold.

Truist Financial first reported a position in FLGT in Q2 2021 and held it in 10 quarters. The position peaked at $2.03M in Q4 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Truist Financial reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Truist Financial sold 10,991 Fulgent Genetics shares in Q1 2024, an estimated $318K.
  • Truist Financial first reported a position in Fulgent Genetics in Q2 2021 and held it in 10 quarters.
  • Truist Financial's Fulgent Genetics position peaked at $2.03M in Q4 2021.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Truist Financial's 13F filing for Q1 2024, filed 13 May 2024.